Hi all
I think an obvious source of funds for the continuing development of the Cardiocell business would be to sell off that part of of our business which is the agency sales of infusion products to local hospitals. Profitable but a small "mum and pop" sized operation. Maybe worth $8 mill or so. Has no value in regards to long term strategy, so why not? Might just allow us to scrape through another year to where the Cardiocell sales turn profitable.
Cheers
- Forums
- ASX - By Stock
- Capital raising share dilution
Hi all I think an obvious source of funds for the continuing...
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.00 |
Change
-0.300(1.64%) |
Mkt cap ! $346.0M |
Open | High | Low | Value | Volume |
$18.29 | $18.30 | $17.65 | $181.7K | 10.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30 | $17.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.00 | 499 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 39 | 17.650 |
2 | 700 | 17.550 |
1 | 1 | 17.510 |
1 | 50 | 17.500 |
1 | 1500 | 17.250 |
Price($) | Vol. | No. |
---|---|---|
18.000 | 499 | 1 |
18.050 | 550 | 1 |
18.300 | 198 | 1 |
18.500 | 43 | 1 |
18.690 | 550 | 1 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |